Skip to main content
. 2016 Aug 23;16(1):673. doi: 10.1186/s12885-016-2698-y

Fig. 1.

Fig. 1

Description of the study participants. BC, breast cancer; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; OC, ovarian cancer; PR, progesterone receptor; TNBC, triple-negative breast cancer